2. Academic Validation
  3. Synthesis and activity of 1-aryl-1'-imidazolyl methyl ethers as non-thiol farnesyltransferase inhibitors

Synthesis and activity of 1-aryl-1'-imidazolyl methyl ethers as non-thiol farnesyltransferase inhibitors

  • Bioorg Med Chem Lett. 2004 Nov 1;14(21):5371-6. doi: 10.1016/j.bmcl.2004.08.011.
Qun Li 1,  Gary T Wang,  Tongmei Li,  Stephen L Gwaltney 2nd,  Keith W Woods,  Akiyo Claiborne,  Xilu Wang,  Wendy Gu,  Jerry Cohen,  Vincent S Stoll,  Charles Hutchins,  David Frost,  Saul H Rosenberg,  Hing L Sham
Affiliations

Affiliation

  • 1 Cancer Research, GPRD, Abbott Laboratories, Abbott Park, IL 60064-6101, USA. [email protected]
PMID: 15454229 DOI: 10.1016/j.bmcl.2004.08.011
Abstract

A series of imidazole-containing methyl ethers (4-5) have been designed and synthesized as potent and selective farnesyltransferase inhibitors (FTIs) by transposition of the D-ring to the methyl group on the imidazole of the previously reported FTIs 3. Several compounds such as 4h and 5b demonstrate superior enzymatic activity to the current benchmark compound tipifarnib (1) with IC(50) values in the lower subnanomolar range, while maintaining excellent cellular activity comparable to tipifarnib. The compounds are characterized as being simple, easier to make, and possess no chiral center involved.

Figures